Abstract
Background Respiratory impairments are adjusted reduction in pulmonary function that manifests with adverse effects on an individual’s state of health. The basis for identifying these impairments requires differentiation between normal and abnormal ventilatory capacity to avoid inaccurate and potentially harmful drug prescriptions and a mismatch of diagnoses. Incentive Spirometry (IS) is a technique designed to help patients achieve a pre-set volume of airflow; the volume is determined from predicted values or baseline measurements.
Methods Fifty-four (54) patients with Obstructive, Restrictive, or Mixed type of respiratory impairments attending the respiratory clinic of Lagos State University Teaching Hospital, Ikeja (LASUTH) will be assessed for eligibility for the study. The study design will be a double-blind, randomized control trial with six intervention groups and three placebo control groups.
The study’s independent variable will be an Inspiratory Incentive Spirometry (IIS) and Expiratory Incentive Spirometry (EIS), while Obstructive, Restrictive, and Mixed respiratory impairments will serve as the dependent variable for the study. Baseline Pulmonary Function Test (PFT) will be assessed on entry into the study, and after every procedure, six minutes’ walk (6MWT) test and CAT assessment test will be assessed at every two (2) weeks interval of the study. Data will be analyzed using descriptive and inferential statistics of repeated ANOVA; P<0.05.
Discussion The study outcome will determine the relationship between inspiratory and expiratory incentive spirometry on respiratory impairments and deduce the best fit device for the respective impairment.
Trial Registration www.pactr.org: PACTR202005904039357
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
www.pactr.org: PACTR202005904039357
Clinical Protocols
https://pactr.samrc.ac.za/Researcher/ManageTrials.aspx
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Biomedical Research Ethics Committee of the University of KwaZulu Natal (South Africa) approved this study with approval number BREC/00001883/2020, and the Human Research Ethics Committee of Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria, West Africa, approved the study site location with approval number LREC/O6/10/1455.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Awolola Eniola Oladejo funds the study. The institution has no interest or role in the study’s design, writing the manuscript, collecting data, and analyzing data. No external funding is received from any source for the study.
Abstract Background: Respiratory impairments are adjusted reduction in pulmonary function that manifests with adverse effects on an individual's state of health. The basis for identifying these impairments requires differentiation between normal and abnormal ventilatory capacity to avoid inaccurate and potentially harmful drug prescriptions and a mismatch of diagnoses. Incentive Spirometry (IS) is a technique designed to help patients achieve a pre-set volume of airflow; the volume is determined from predicted values or baseline measurements. Methods: Fifty-four (54) patients with Obstructive, Restrictive, or Mixed type of respiratory impairments attending the respiratory clinic of Lagos State University Teaching Hospital, Ikeja (LASUTH) will be assessed for eligibility for the study. The study design will be a double-blind, randomized control trial with six intervention groups and three placebo control groups. The study's independent variable will be an Inspiratory Incentive Spirometry (IIS) and Expiratory Incentive Spirometry (EIS), while Obstructive, Restrictive, and Mixed respiratory impairments will serve as the dependent variable for the study. Baseline Pulmonary Function Test (PFT) will be assessed on entry into the study, and after every procedure, six minutes' walk (6MWT) test and CAT assessment test will be assessed at every two (2) weeks interval of the study. Data will be analyzed using descriptive and inferential statistics of repeated ANOVA; P<0.05. Discussion: The study outcome will determine the relationship between inspiratory and expiratory incentive spirometry on respiratory impairments and deduce the best fit device for the respective impairment. Trial Registration: www.pactr.org: PACTR202005904039357 Keywords: Respiratory Impairment, Incentive Spirometry, COPD, 6MWT, PFT, CAT SCORE
Data Availability
All data would be collected on a sheet of papers (form) and kept confidential under lock & key and transfer to excel sheet electronically on a password protected computer at the Physiotherapy department, college of health sciences, University of KwaZulu-Natal, Durban for 5 years, only the researchers will have access to it after this period all documentation will be destroyed.
Abbreviations
- 6MWT
- Six Minutes’ Walk Test
- ANOVA
- Analysis of Variance
- CAT
- COPD Assessment Test
- COPD
- Chronic Obstructive Pulmonary Disease
- EIS
- Expiratory Incentive Spirometry
- FEV1
- Forced Expiratory Volume on 1 Second.
- FRC
- Functional Residual Capacity
- FVC
- Forced Vital Capacity
- GLI
- Global lung Initiative.
- IIS
- Inspiratory Incentive Spirometry
- LASUTH
- Lagos State University Teaching Hospital
- LLN
- Lower Limit of Normal
- MANOVA
- Multiple Analyses of Variance
- MS
- Microsoft
- PFT
- Pulmonary Function Test
- RCT
- Randomized Control Trial
- ROM
- Range of Motion
- SPSS
- Statistical Package for Social Sciences
- UKZN
- University of Kwazulu-Natal